127 related articles for article (PubMed ID: 15158791)
1. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors.
Roger G; Dollé F; De Bruin B; Liu X; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Bottlaender M; Valette H; Kassiou M
Bioorg Med Chem; 2004 Jun; 12(12):3229-37. PubMed ID: 15158791
[TBL] [Abstract][Full Text] [Related]
2. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
[TBL] [Abstract][Full Text] [Related]
3. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
Coughenour LL; Barr BM
J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
[TBL] [Abstract][Full Text] [Related]
4. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4-benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[(11)C]one, as a potent NR(1A)/2B subtype selective NMDA PET radiotracer.
Roger G; Lagnel B; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Kassiou M; Bottlaender M; Valette H; Dollé F
Bioorg Med Chem; 2003 Dec; 11(24):5401-8. PubMed ID: 14642584
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
[TBL] [Abstract][Full Text] [Related]
7. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
11. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
[TBL] [Abstract][Full Text] [Related]
12. Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidine.
Arstad E; Platzer S; Berthele A; Pilowsky LS; Luthra SK; Wester HJ; Henriksen G
Bioorg Med Chem; 2006 Sep; 14(18):6307-13. PubMed ID: 16777419
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of radio-iodinated benzimidazoles as SPECT imaging agents for NR2B subtype of NMDA receptor.
Fuchigami T; Yamaguchi H; Ogawa M; Biao L; Nakayama M; Haratake M; Magata Y
Bioorg Med Chem; 2010 Nov; 18(21):7497-506. PubMed ID: 20875744
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors.
Labas R; Gilbert G; Nicole O; Dhilly M; Abbas A; Tirel O; Buisson A; Henry J; Barré L; Debruyne D; Sobrio F
Eur J Med Chem; 2011 Jun; 46(6):2295-309. PubMed ID: 21453995
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (+/-)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors.
Haradahira T; Maeda J; Okauchi T; Zhang MR; Hojo J; Kida T; Arai T; Yamamoto F; Sasaki S; Maeda M; Suzuki K; Suhara T
Nucl Med Biol; 2002 Jul; 29(5):517-25. PubMed ID: 12088721
[TBL] [Abstract][Full Text] [Related]
16. In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine.
Hashimoto K; Scheffel U; London ED
Synapse; 1995 May; 20(1):85-90. PubMed ID: 7624833
[TBL] [Abstract][Full Text] [Related]
17. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
[TBL] [Abstract][Full Text] [Related]
18. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.
Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M
Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396
[TBL] [Abstract][Full Text] [Related]
20. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
